References
- Gregory VM, Russell FE, Brewer JR, Zawadski LR. Seasonal variations in rattlesnake venom proteins. Proc West Pharmacol Soc 1984; 27: 233–236
- Chippaux JP, Williams V, White J. Snake venom variability: Methods of study, results and interpretation. Toxicon 1991; 29(11)1279–1303
- Brick JF, Guttmann L. Rattlesnake venom-induced myokymia. Muscle & Nerve 1982; s98–s100
- LoVecchio F, Pizon AF, Wallace KL, Kunkel DB. Myokymia after snake envenomation in Arizona. Wilderness Environ Med 2005; 16(2)116–7
- Lewis RL, Gutmann L. Snake venoms and the neuromuscular junction. Semin Neurol 2004; 24(2)175–9
- Clark RF, Williams SR, Nordt SP, Boyer-Hassen LV. Successful treatment of Crotalid-induced neurotoxicity with a new polyspecific Crotalid FAV antivenom. Ann Emerg Med 1997; 30(1)54–57
- Gutmann L, Gutmann L. Timber rattlesnake myokymia. J Periph Nerv Syst 2003; 8: 19
- Brick JF, Gutmann L, Brick RN, et al. Timber rattlesnake venom-induced myokymia: Evidence for peripheral nerve origin. Neurology 1987; 37: 1545–1546
- Bush SP, Siedenburg E. Neurotoxicity associated with suspected southern Pacific rattlesnake (Crotalus viridis helleri) envenomation. Wilderness Env Med 1999; 10(4)247–9